CSIMarket
 


Zymeworks Inc   (ZYME)
Other Ticker:  
 
 

ZYME's Free Cash Flow Growth by Quarter and Year

Zymeworks Inc 's Free Cash Flow results by quarter and year




ZYME Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 13.95 327.36 -101.30 -16.06
III Quarter September -42.67 -73.02 -50.35 -49.96
II Quarter June -6.40 -54.82 -40.80 -37.49
I Quarter March -83.19 -55.41 -47.90 -36.35
FY   -118.31 144.11 -240.35 -139.86



ZYME Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Zymeworks Inc reported drop in Free Cash Flow in the fourth quarter 2023 by -95.74% to $ 13.95 millions, from the same quarter in 2022.
This represents worst decline in recent Company history.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 30 other companies have achieved higher Free Cash Flow growth. While Zymeworks Inc ' s Free Cash Flow meltdown of -95.74% ranks overall at the positon no. 1378 in the fourth quarter 2023.




ZYME Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -95.74 % - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Zymeworks Inc 's fourth quarter 2023 Free Cash Flow $ 13.95 millions ZYME's Income Statement
Zymeworks Inc 's fourth quarter 2022 Free Cash Flow $ 327.36 millions Quarterly ZYME's Income Statement
New: More ZYME's historic Free Cash Flow Growth >>


ZYME Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #115
Overall #1378

Free Cash Flow Y/Y Growth Statistics
High Average Low
-95.74 % -95.74 % -95.74 %
(Dec 31 2023)  
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #115
Overall #1378
Free Cash Flow Y/Y Growth Statistics
High Average Low
-95.74 % -95.74 % -95.74 %
(Dec 31 2023)  

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Zymeworks Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ZYME's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2023Cyclical Zymeworks Inc in the circumstances free cash outflow of $ 13.95 millionsCyclical circumstances have contributed Zymeworks Inc 's restoration of profitability, as ZYME postFree Cash Flow of $ 13.95 millions in the IV. Quarter 2023 emanate free cash outflow-42.67 millions in the third quarter. Zymeworks Inc announced in the IV. Quarter 2023 Free Cash Flow of $ 13.95 millions compare to free cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zymeworks Inc achieved highest sequential Free Cash Flow growth. While Zymeworks Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ZYME's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2023Periodic Zymeworks Inc in the influence free cash outflow of $ 13.95 millionsPeriodic influence have added to Zymeworks Inc 's rebound to recovery, as ZYME deliverFree Cash Flow of $ 13.95 millions in the IV. Quarter 2023 emanate free cash outflow-42.67 millions in the third quarter. Zymeworks Inc announced in the IV. Quarter 2023 Free Cash Flow of $ 13.95 millions compare to free cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zymeworks Inc achieved highest sequential Free Cash Flow growth. While Zymeworks Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Zymeworks Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -114.23 $ 198.31 $ 170.62 $ 125.14 $ 157.23
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - 16.23 % 36.34 % -20.41 % -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1411 # 1814 # 1610 # 1557 # 0




Cumulative Free Cash Flow growth Comment
Zymeworks Inc realized trailing twelve months free cash outflow of $ -114 millions, in the Dec 31 2023, compare to Free Cash Flow of $ 157 millions a year ago.

Zymeworks Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
243.49 %
-575.03 %
-1824.12 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 104
S&P 500 # 1411
Cumulative Free Cash Flow growth Comment
Zymeworks Inc realized trailing twelve months free cash outflow of $ -114 millions, in the Dec 31 2023, compare to Free Cash Flow of $ 157 millions a year ago.

Zymeworks Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
243.49 %
-575.03 %
-1824.12 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 104
S&P 500 # 1411




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ZYME's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ZYME's Competitors
Free Cash Flow Growth for Zymeworks Inc 's Suppliers
Free Cash Flow Growth for ZYME's Customers

You may also want to know
ZYME's Annual Growth Rates ZYME's Profitability Ratios ZYME's Asset Turnover Ratio ZYME's Dividend Growth
ZYME's Roe ZYME's Valuation Ratios ZYME's Financial Strength Ratios ZYME's Dividend Payout Ratio
ZYME's Roa ZYME's Inventory Turnover Ratio ZYME's Growth Rates ZYME's Dividend Comparisons



Companies with similar Free Cash Flow meltdown for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Sanofi-2.55%$ -2.546 millions
Inmode Ltd -2.62%$ -2.617 millions
Charles River Laboratories International inc -5.88%$ -5.884 millions
Mettler toledo International Inc -7.29%$ -7.291 millions
Envista Holdings Corporation-7.52%$ -7.525 millions
Bio rad Laboratories Inc -10.37%$ -10.366 millions
Inspire Medical Systems inc -10.39%$ -10.390 millions
Insulet Corporation-10.85%$ -10.848 millions
Laboratory Corporation Of America Holdings-11.32%$ -11.322 millions
Hologic Inc-13.18%$ -13.181 millions
Neurocrine Biosciences Inc -13.64%$ -13.636 millions
Gilead Sciences Inc -15.50%$ -15.504 millions
Bausch Health Companies Inc -17.89%$ -17.895 millions
Koru Medical Systems Inc-17.93%$ -17.932 millions
Progyny Inc -26.90%$ -26.900 millions
Ufp Technologies Inc -29.00%$ -28.997 millions
Enhabit Inc -29.27%$ -29.268 millions
Integra Lifesciences Holdings Corp-31.15%$ -31.153 millions
Cryoport inc -32.07%$ -32.074 millions
Qiagen N v -35.76%$ -35.764 millions
Abbvie inc -36.01%$ -36.012 millions
Regeneron Pharmaceuticals Inc -36.64%$ -36.642 millions
Pfizer Inc-38.94%$ -38.942 millions
Axonics Inc -39.81%$ -39.805 millions
Warby Parker Inc -42.68%$ -42.678 millions
Catalent Inc -47.66%$ -47.664 millions
Intuitive Surgical Inc -47.86%$ -47.865 millions
Incyte Corporation-47.92%$ -47.921 millions
Jazz Pharmaceuticals Plc-51.07%$ -51.066 millions
Edwards Lifesciences Corporation-51.70%$ -51.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com